BCTBriaCell Therapeutics Corp
Slide 1 of 3
Company Overview
Name
BriaCell Therapeutics Corp
52W High
52W Low
Market Cap
$13.3M
Dividend Yield
0%
Price/earnings
-62.19
P/E
-62.19
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
$-27.2M
Net Income
$-26.6M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.74
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$5.9M
Research & Development Expense
$21.3M
Total Operating Expenses
$-27.2M
Interest & Investment Income
$-224.2K
Other Income / (Expense), net
$872.9K
Total Other Income / (Expense), net
$648.7K
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
BriaCell Therapeutics Corp
52W High
52W Low
Market Cap
$13.3M
Dividend Yield
0%
Price/earnings
-62.19
P/E
-62.19
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
$-27.2M
Net Income
$-26.6M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.74
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$5.9M
Research & Development Expense
$21.3M
Total Operating Expenses
$-27.2M
Interest & Investment Income
$-224.2K
Other Income / (Expense), net
$872.9K
Total Other Income / (Expense), net
$648.7K
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
William V. Williams
Location
British Columbia, Canada
Exchange
Nasdaq
Website
https://briacell.com
Summary
BriaCell Therapeutics Corp.
Company Info
CEO
William V. Williams
Location
British Columbia, Canada
Exchange
Nasdaq
Website
https://briacell.com
Summary
BriaCell Therapeutics Corp.
